1) Drug-carrying microbubble
载药微泡
2) drug loading
载药
1.
The mesoporous molecular sieve MCM-41 is synthesized by microwave radiation method,diuretic drugs is assembled into the passway of mesoporous molecular sieve MCM-41 by the impregnation,the MCM-41 and drug assemblies are eharactered by XRD,low temperature N_2 adsorption,IR,drug loading rate,drug loading time and the release rate in the vitro(artificial gastric juice)of the assemblies is determined.
用微波辐射法合成介孔分子筛MCM-41,采用浸溃法将利尿药物氢氯噻嗪组装到介孔分子筛MCM-41孔道中,用XRD、低温N_2吸附、IR对MCM-41及药物组装体进行了表征;研究了组装体的载药量、载药时间、在体外人工胃液中的释放等。
3) drug-loaded
载药
1.
Properties of Drug-loaded Chitosan Microspheres Crosslinked by Vanillin and Analysis of Microsphere-forming Mechanism;
香草醛交联壳聚糖载药微球的性能及其成球机理分析
4) drug loading
载药率
1.
The factors affecting the morphology and the encapsulation efficiency of the microcapsules were investigated,and the drug loading was also determined.
采用原位聚合法以脲醛树脂为壁材制备了毒死蜱微胶囊,考察了制备过程中微胶囊表面形貌、包封率的影响因素,并测定了微胶囊的载药率。
5) drug loading
载药量
1.
The diameter,entrapment efficiency,drug loading, zeta potential and stability of DT-13-SLN were investigated.
方法:以乳化-蒸发法制备DT-13-SLN,通过正交设计优化处方和制备工艺条件,测定其粒径、zeta电位、药物包封率和载药量,以透射电镜观察纳米粒形态,并考察DT-13-SLN的稳定性,对DT-13-SLN的冻干粉进行差示扫描量热(DSC)分析,以确定DT-13-SLN的生成。
2.
The orthogonal test design by adopting the standard of drug encapsulation efficiency and drug loading was applied to obtain the optimal formulation of the microcapsula.
以药物的包封率和载药量作为制备工艺优化指标,通过正交试验得出微囊的最优处方。
3.
Properties of mitomycin C albumin microspheres were investigated,including particle size,drug loading capacity,embedding ratio and drug sustained release property in vitro.
以人血清白蛋白为载体材料,精制棉籽油为油相,采用乳化热固法制备了抗癌丝裂霉素C白蛋白微球,对丝裂霉素C白蛋白微球的粒径、载药量、包封率以及药物的体外释药等特性进行了研究。
6) loading capacity
载药量
1.
Their properties including size,Zeta potential,microcosmic morphology,loading capacity and stability were investigated by photon correlation spectroscopy(PCS),Z.
NLC作为ATRA的药物载体,载药量提高到146。
2.
Drug loading capacity was analyzed by agarose gel electrophoresis.
方法 逆相蒸发法制备 3种不同的空白脂质体 ,与反义寡核苷酸混合得到复合物 ,显微镜观察其形态 ,琼脂糖电泳分析载药量 ,流式细胞仪测定阳性细胞百分率和平均荧光强度。
参考词条
补充资料：CO2微泡超声血管造影
CO2微泡超声血管造影
影像学术语。利用CO2微泡作为声学对比剂施行的超声血管成像方法。利用两个注射器与三通管连接，将10ml CO2、10ml肝素化生理盐水及5ml病人自身血液充分混匀制成CO2微泡。常规肝动脉造影后经置于肝固有动脉(或左、右分支)内的导管，以2ml/s的速度缓慢注入CO2微泡。根据CO2微泡在肝实质内充盈程度分为早、中、晚三期。CO2微泡开始充盈肝实质为早期，历时5～10s；CO2微泡持续充盈肝实质为中期，约10～60s；完全从肝实质内清除为晚期，相当于注入CO2微泡后的1～7分钟。此方法的所见与血管造影静脉期相似，但发现小病灶优于血管造影。CO2-Dus对血管造影不能显示的等血管性或少血管性肝细胞癌有价值。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。